Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 35 of 1714:
25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45
Gene Compound Assay Inh Ic50 Ki View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PHENTOLAMINE Calcium Channel Type L, Phenylalkylamine 73% .746uM .725uM View
Cytochrom P450-1A2 monooxygenase SB-203580 CYP450-1A2 Inhibition 73% 2uM NoneNone View
adrenergic receptor, beta 1 SOTALOL Adrenergic beta1 73% 1.4434uM .8335uM View
adrenergic, beta-1-, receptor SOTALOL Adrenergic beta1 73% 1.4434uM .8335uM View
opioid receptor, sigma 1 ASTEMIZOLE Sigma1 73% 2.246uM .944uM View
adrenergic receptor, beta 2 DOXAZOSIN Adrenergic beta2 73% 2.748uM 1.889uM View
5-hydroxytryptamine receptor 6 HALOPROGIN Serotonin 5-HT6 73% 4.011uM 1.862uM View
phosphodiesterase 4A, cAMP specific CLADRIBINE Phosphodiesterase PDE4 73% 3.625uM NoneNone View
phosphodiesterase 4C, cAMP-specific CLADRIBINE Phosphodiesterase PDE4 73% 3.625uM NoneNone View
phosphodiesterase 4D CLADRIBINE Phosphodiesterase PDE4 73% 3.625uM NoneNone View
phosphodiesterase 4B, cAMP specific CLADRIBINE Phosphodiesterase PDE4 73% 3.625uM NoneNone View
adrenergic receptor, alpha 2b THIMEROSAL Adrenergic alpha2C 73% 5.041uM .732uM View
adrenergic receptor, alpha 2c (Non-specific probe) THIMEROSAL Adrenergic alpha2C 73% 5.041uM .732uM View
A3 adenosine receptor BENZBROMARONE Adenosine A3 73% 5.222uM 2.952uM View
arachidonate 15-lipoxygenase, second type DIPYRIDAMOLE Lipoxygenase 15-LO 73% 6.956uM NoneNone View
arachidonate 15-lipoxygenase DIPYRIDAMOLE Lipoxygenase 15-LO 73% 6.956uM NoneNone View
arachidonate 15-lipoxygenase DIPYRIDAMOLE Lipoxygenase 15-LO 73% 6.956uM NoneNone View
estrogen receptor 1 CAFFEIC ACID PHENETHYL ESTER Estrogen ERalpha 73% 7.912uM 2.26uM View
estrogen receptor 1 CAFFEIC ACID PHENETHYL ESTER Estrogen ERalpha 73% 7.912uM 2.26uM View
dopamine receptor D1A DOXEPIN Dopamine D1 73% .688uM .344uM View
opioid receptor, sigma 1 DOXEPIN Sigma1 73% .631uM .265uM View
Cytochrom P450-2E1 monooxygenase CARBON TETRACHLORIDE CYP450-2E1 Inhibition 73% 11uM NoneNone View
adrenergic receptor, alpha 2a HALOPERIDOL Adrenergic alpha2A 73% 4.973uM 1.865uM View
5-hydroxytryptamine (serotonin) receptor 2C HALOPERIDOL Serotonin 5-HT2C 73% 3.347uM 1.753uM View
histamine receptor H 1 HALOPERIDOL Histamine H1, Central 73% 2.781uM .323uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 MONOBENZONE Adrenergic, Norepinephrine Transporter 73% 3.886uM 3.854uM View
5-hydroxytryptamine (serotonin) receptor 1A VERAPAMIL Serotonin 5-HT1A 73% 3.02uM 1.726uM View
Cytochrom P450-1A2 monooxygenase 1-NAPHTHYL ISOTHIOCYANATE CYP450-1A2 Inhibition 73% 1uM NoneNone View
adrenergic receptor, alpha 2a TIAPRIDE Adrenergic alpha2A 73% 2.078uM .779uM View
5-hydroxytryptamine (serotonin) receptor 2B MITOTANE Serotonin 5-HT2B 73% 4.832uM 3.075uM View
cholinergic receptor, muscarinic 5 TROPISETRON Muscarinic M5 73% 3.45uM 2.479uM View
histamine receptor H 2 KETOTIFEN Histamine H2 73% 4.129uM 4.06uM View
adrenergic receptor, beta 1 CLORPRENALINE Adrenergic beta1 73% 2.592uM 1.497uM View
adrenergic, beta-1-, receptor CLORPRENALINE Adrenergic beta1 73% 2.592uM 1.497uM View
Cytochrom P450-1A2 monooxygenase PROPRANOLOL CYP450-1A2 Inhibition 73% 4uM NoneNone View
mitogen activated protein kinase 1 ACECLOFENAC Protein Serine/Threonine Kinase, ERK2 73% 5.927uM NoneNone View
mitogen-activated protein kinase 1 ACECLOFENAC Protein Serine/Threonine Kinase, ERK2 73% 5.927uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 OXYBUTYNIN Adrenergic, Norepinephrine Transporter 73% 2.5951uM 2.5737uM View
5-hydroxytryptamine (serotonin) receptor 2B ORPHENADRINE Serotonin 5-HT2B 73% 3.391uM 2.158uM View
sodium channel, nonvoltage-gated 1 alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, nonvoltage-gated 1 gamma OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, nonvoltage-gated 1 beta OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type XI, alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, nonvoltage-gated 1, gamma OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, nonvoltage-gated 1, delta OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, nonvoltage-gated 1 alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type X, alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type IX, alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage gated, type VIII, alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type VII, alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type IV, beta OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type IV, alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type III, alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type II, beta OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type II, alpha 2 OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type I, beta OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type I, alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
adrenergic receptor, alpha 2b OXYMETAZOLINE Adrenergic alpha2C 73% 2.633uM .383uM View
adrenergic receptor, alpha 2c (Non-specific probe) OXYMETAZOLINE Adrenergic alpha2C 73% 2.633uM .383uM View
sodium channel, voltage-gated, type IV, beta OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel associated protein 1 OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel associated protein 2 OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type III, beta OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type I, alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type IX, alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type VII, alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
amiloride-sensitive cation channel 5, intestinal OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type III, beta OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type XI, alpha OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type I, beta OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
sodium channel, voltage-gated, type 10, alpha polypeptide OXYMETAZOLINE Sodium Channel, Site 2 73% 3.45uM 3.148uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit DIPHENIDOL Calcium Channel Type L, Phenylalkylamine 73% 4.501uM 4.376uM View
calcium channel, voltage-dependent, alpha 1F subunit DIPHENIDOL Calcium Channel Type L, Phenylalkylamine 73% 4.501uM 4.376uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit DIPHENIDOL Calcium Channel Type L, Phenylalkylamine 73% 4.501uM 4.376uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit DIPHENIDOL Calcium Channel Type L, Phenylalkylamine 73% 4.501uM 4.376uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DIPHENIDOL Calcium Channel Type L, Phenylalkylamine 73% 4.501uM 4.376uM View
calcium channel, voltage-dependent, beta 1 subunit DIPHENIDOL Calcium Channel Type L, Phenylalkylamine 73% 4.501uM 4.376uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit DIPHENIDOL Calcium Channel Type L, Phenylalkylamine 73% 4.501uM 4.376uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit DIPHENIDOL Calcium Channel Type L, Phenylalkylamine 73% 4.501uM 4.376uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DIPHENIDOL Calcium Channel Type L, Phenylalkylamine 73% 4.501uM 4.376uM View
adrenergic receptor, alpha 1b DIPHENIDOL Adrenergic alpha1B 73% 4.76uM 2.635uM View
dopamine receptor 2 DIPHENIDOL Dopamine D2L 73% 3.29uM 1.097uM View
5-hydroxytryptamine (serotonin) receptor 1A CLONIDINE Serotonin 5-HT1A 73% 5.365uM 3.066uM View
opioid receptor, sigma 1 BUTENAFINE Sigma1 73% 3.9533uM 1.6615uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) DIHYDROERGOCRISTINE MESYLATE CYP450-2C9 Inhibition 73% 3uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 DIHYDROERGOCRISTINE MESYLATE CYP450-2C9 Inhibition 73% 3uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 TERBINAFINE Adrenergic, Norepinephrine Transporter 73% 4.1295uM 4.0954uM View
5-hydroxytryptamine (serotonin) receptor 1A PROCHLORPERAZINE Serotonin 5-HT1A 73% .95uM .543uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) TROGLITAZONE CYP450-2C9 Inhibition 73% 4uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 TROGLITAZONE CYP450-2C9 Inhibition 73% 4uM NoneNone View
mu-opioid receptor MOR DISULFIRAM Opiate mu 73% 3.511uM 1.425uM View
progesterone receptor MICONAZOLE Progesterone 73% 14.912uM 1.945uM View
progesterone receptor MICONAZOLE Progesterone 73% 14.912uM 1.945uM View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 PREDNISONE Adenosine Transporter 73% 4.947uM 1.692uM View
concentrative Na+ nucleoside cotransporter (DBSS) PREDNISONE Adenosine Transporter 73% 4.947uM 1.692uM View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 PREDNISONE Adenosine Transporter 73% 4.947uM 1.692uM View
adenine nucleotide translocase (DBSS) (Non-specific probe) PREDNISONE Adenosine Transporter 73% 4.947uM 1.692uM View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 PREDNISONE Adenosine Transporter 73% 4.947uM 1.692uM View
progesterone receptor ECONAZOLE Progesterone 73% 10.208uM 1.332uM View
progesterone receptor ECONAZOLE Progesterone 73% 10.208uM 1.332uM View
melanocortin 3 receptor ECONAZOLE Melanocortin MC3 73% 36.009uM 31.426uM View
melanocortin 3 receptor ECONAZOLE Melanocortin MC3 73% 36.009uM 31.426uM View
5-hydroxytryptamine (serotonin) receptor 2C MICONAZOLE Serotonin 5-HT2C 73% 5.314uM 2.784uM View
dopamine receptor D1A DANAZOL Dopamine D1 73% 20.449uM 10.225uM View
adrenergic receptor, beta 1 DIETHYLSTILBESTROL Adrenergic beta1 73% 22.088uM 12.755uM View
adrenergic, beta-1-, receptor DIETHYLSTILBESTROL Adrenergic beta1 73% 22.088uM 12.755uM View
opioid receptor, kappa 1 MIFEPRISTONE Opiate kappa 73% 20.096uM 8.038uM View
prostaglandin-endoperoxide synthase 1 4-OCTYLPHENOL Cyclooxygenase COX-1 73% 10.319uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) 4-OCTYLPHENOL Cyclooxygenase COX-1 73% 10.319uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 1B BACITRACIN Serotonin 5-HT1B 73% 2.978uM 1.354uM View
nuclear receptor subfamily 3, group C, member 1 TESTOSTERONE Glucocorticoid 73% 3.206uM 1.457uM View
phosphodiesterase 4A, cAMP specific ALPHA-NAPHTHOFLAVONE Phosphodiesterase PDE4 73% 2.9197uM NoneNone View
phosphodiesterase 4C, cAMP-specific ALPHA-NAPHTHOFLAVONE Phosphodiesterase PDE4 73% 2.9197uM NoneNone View
phosphodiesterase 4D ALPHA-NAPHTHOFLAVONE Phosphodiesterase PDE4 73% 2.9197uM NoneNone View
phosphodiesterase 4B, cAMP specific ALPHA-NAPHTHOFLAVONE Phosphodiesterase PDE4 73% 2.9197uM NoneNone View
arachidonate 15-lipoxygenase, second type DOXORUBICIN Lipoxygenase 15-LO 73% 13.59uM NoneNone View
arachidonate 15-lipoxygenase DOXORUBICIN Lipoxygenase 15-LO 73% 13.59uM NoneNone View
arachidonate 15-lipoxygenase DOXORUBICIN Lipoxygenase 15-LO 73% 13.59uM NoneNone View
caspase 1 DOXORUBICIN Protease, Caspase 1 73% 12.192uM NoneNone View
caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) DOXORUBICIN Protease, Caspase 1 73% 12.192uM NoneNone View
caspase 3, apoptosis related cysteine protease DOXORUBICIN Protease, Caspase 1 73% 12.192uM NoneNone View
caspase 2 DOXORUBICIN Protease, Caspase 1 73% 12.192uM NoneNone View
caspase 7 DOXORUBICIN Protease, Caspase 1 73% 12.192uM NoneNone View
caspase 6 DOXORUBICIN Protease, Caspase 1 73% 12.192uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 AMLODIPINE Dopamine Transporter 73% 5.521uM 4.387uM View
androgen receptor CLOTRIMAZOLE Testosterone 73% 11.586uM 7.724uM View
histamine receptor H 2 CLOTRIMAZOLE Histamine H2 73% 5.165uM 5.079uM View
chemokine (C-C motif) receptor 4 AMIODARONE Chemokine CCR4 73% 21.773uM 11.405uM View
angiotensin 1 converting enzyme 1 BLEOMYCIN A2 Protease, Angiotensin Converting Enzyme 73% .588uM NoneNone View
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 BLEOMYCIN A2 Protease, Angiotensin Converting Enzyme 73% .588uM NoneNone View
Cytochrom P450-2D6 monooxygenase 1-BENZYLIMIDAZOLE CYP450-2D6 Inhibition 73% 2uM NoneNone View
melanocortin 3 receptor TAMOXIFEN Melanocortin MC3 73% 19.856uM 17.329uM View
melanocortin 3 receptor TAMOXIFEN Melanocortin MC3 73% 19.856uM 17.329uM View
dopamine receptor D1A DIHYDROERGOTAMINE Dopamine D1 73% 2.395uM 1.197uM View
Sigma-2 Receptor CLOMIPRAMINE Sigma2 73% 1.876uM 1.155uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 MAPROTILINE CYP450-3A4 Inhibition 73% 4.322uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, gamma subunit 7 BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, gamma subunit 6 BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, gamma subunit 5 BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, gamma subunit 4 BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, gamma subunit 3 BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, gamma subunit 2 BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, gamma subunit 1 BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, beta 4 subunit BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, beta 3 subunit BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, beta 2 subunit BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, alpha 1F subunit BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
calcium channel, voltage-dependent, beta 1 subunit BW-723C86 Calcium Channel Type L, Benzothiazepine 73% 3.4696uM 3.0841uM View
Sigma-2 Receptor PROPRANOLOL Sigma2 72% 3.467uM 2.134uM View
calcium channel, voltage-dependent, gamma subunit 4 LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, gamma subunit 3 LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, gamma subunit 2 LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, gamma subunit 1 LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, beta 4 subunit LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, beta 3 subunit LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, beta 2 subunit LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, alpha 1F subunit LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, beta 1 subunit LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 LOVASTATIN Calcium Channel Type L, Phenylalkylamine 72% 6.318uM 6.142uM View
mu-opioid receptor MOR CHLORPROMAZINE Opiate mu 72% 14.397uM 5.844uM View
cholinergic receptor, muscarinic 4 AMIODARONE Muscarinic M4 72% 3.63uM .506uM View
matrix metallopeptidase 9 CATECHOL Protease, Matrix Metalloprotease-9 (MMP-9) 72% 23.367uM NoneNone View
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) CATECHOL Protease, Matrix Metalloprotease-9 (MMP-9) 72% 23.367uM NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type IV, beta DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type IV, alpha DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type III, alpha DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type II, beta DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type II, alpha 2 DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type I, beta DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type I, alpha DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type IV, beta DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel associated protein 1 DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel associated protein 2 DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type III, beta DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type I, alpha DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type IX, alpha DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type VII, alpha DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
amiloride-sensitive cation channel 5, intestinal DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type III, beta DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
sodium channel, voltage-gated, type XI, alpha DIHYDROERGOTAMINE Sodium Channel, Site 2 72% 5.058uM 4.614uM View
potassium voltage-gated channel, subfamily H, member 8 CHLORPROMAZINE Potassium Channel HERG 72% 5.8275uM 4.7743uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 CHLORPROMAZINE Potassium Channel HERG 72% 5.8275uM 4.7743uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 CHLORPROMAZINE Potassium Channel HERG 72% 5.8275uM 4.7743uM View